NATCO Pharma Limited

NSE:NATCOPHARM.NS

1407.15 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income 13,8838,6192,0225,7965,6878,2478,8726,2442,066.2381,342.1721,289.7681,023.193795.418651.232616.098552.615553.175397.913272.1677.497
Depreciation & Amortization 1,8681,6381,4261,169998810662544509.525472.657304.434221.223159.079158.816211.503140.57689.96877.89966.6558.418
Deferred Income Tax 00-462-1,541-1,075-2,005-2,032-1,007-283.04600-241.596000-90.154-135.373-10.71516.439217.719
Stock Based Compensation 002212614425318012396.860057.1130000.627.84514.82740.96610.948
Change In Working Capital -3,094627-2,314-2,129-97688-2,946-2,528-1,499.942-859.567-161.13-673.935-279.714-178.97-112.373-358.471-44.412-72.82121.31795.609
Accounts Receivables -3,413-2,221-2,3521,257-5931,363-1,752-2,374-788-718.587112.918-349.72200000000
Inventory 424191564-2,402-289-906-89584-1,385.676-395.775-358.82-343.856-85.32-250.228-28.225-125.084-166.608-59.363-77.509-10.007
Accounts Payables -2811,02074-1,095417-51264-1291,50200000000000
Other Working Capital 1761,637-600111-511143-2,051-2,612-114.266-463.792197.69-330.079-194.39371.258-84.148-233.387122.197-13.45898.825105.616
Other Non Cash Items 6,872-2,393-229-433-605-705-10082134.161-28.67.272225.949-25.37644.89558.466128.66612.69742.925-105.72699.5
Operating Cash Flow 12,5238,4914652,9884,1736,6884,6363,4581,023.797926.6621,440.344611.947649.407675.973773.694373.853483.901450.028311.813489.692
Investing Activities:
Investments In Property Plant And Equipment -3,587-2,056-2,427-2,546-3,586-4,617-4,243-2,795-1,573.705-1,192.101-1,103.66-1,116.812-1,285.22-959.426-374.859-544.117-667.489-342.261-320.667-238.814
Acquisitions Net 20201-1,0311,1511,06618018577230018.84917.059-213.498000087.7190
Purchases Of Investments -15,957-5,363-913-1,846-2,469-1,295-5,694-579-208.45900-9.13-5.353-23.657-3.07100-20.976-135.397-283.069
Sales Maturities Of Investments 8,5971,0882,9524,3241,203-18004132625.6281511.793.6173.0530016.3520282.122157.465
Other Investing Activites 121,3591,366-2,1162,116-210-1,218-11027.2318.972-0.56624.570.529-0.391-230.56717.49648.521-22.524-112.05449.607
Investing Cash Flow -10,915-4,771-53-1,033-1,670-6,122-11,155-2,994-1,754.934-1,147.501-1,089.226-1,070.734-1,269.368-1,193.919-608.497-526.621-602.616-385.761-198.277-314.811
Financing Activities:
Debt Repayment -1,978-2,390-1,382-484-229-2,131-484-142-1,291.376-14.812-419.903-509.673-270.278-428.121-818.969000-449.041-382.334
Common Stock Issued 02,390011-2,1318,95603,344.44601,085.282.25167501.07101.0451.11610.1327.798
Common Stock Repurchased -2,537-740-140-1,337-1,34700-948.6120-834.254890.458320.0890595.284000111.5120
Dividends Paid -1,708-1,004-822-1,139-1,536-1,108-1,814-1,409-260.692-199.329-193.486-143.578-106.721-65.219-106.422-0.08-33.988-33.455-32.8620
Other Financing Activities 1,797-2,5522,552-955936,208-633-15812.366490.0799.70423.6439.6621,264.366-12.414184.103124.556-51.53289.83610.39
Financing Cash Flow -2,288-3,630348-1,857-2,508-5096,509-1,709856.132290.75-352.659263.101627.752771.025-341.449184.02391.612-83.872-270.43255.855
Other Information:
Effect Of Forex Changes On Cash 6511893-38-809-86-7.753-47.654.178-51.24121.686-1.42-28.14800000
Net Change In Cash 8,16320885360-8566-18-1,239117.24122.2612.637-246.92729.478251.659-204.431.255-27.103-19.605-156.894430.735
Cash At End Of Period 9,5291,3191,111258198283217-1,981241.658124.416102.15599.518346.445321.11769.458290.923259.668286.771306.376463.27